Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient

Abrams, 1979, Prospects for accelerating hematopoietic recovery following myelosuppressive therapy by using autologous, cryopreserved hematopoietic stem cells collected solely from the peripheral blood, Exp Hematol, 7, 107 Stiff, 1983, Quantification of the peripheral blood colony forming unit-culture rise following chemotherapy. Could leukocytapheresis replace bone marrow for autologous transplantation?, Transfusion, 23, 500, 10.1046/j.1537-2995.1983.23684074271.x Sheridan, 1992, Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy, Lancet, 339, 640, 10.1016/0140-6736(92)90795-5 Dreger, 1995, Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts, Blood, 86, 2970, 10.1182/blood.V86.10.3970.bloodjournal86103970 Stiff, 1997, Management strategies for the hard to mobilize patient, Bone Marrow Transplant, 23, 529 Bensinger, 1995, Factors that influence collection and engraftment of autologous peripheral-blood stem cells, J Clin Oncol, 13, 2547, 10.1200/JCO.1995.13.10.2547 Haas, 1994, Patient characteristics associate with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma, Blood, 83, 3787, 10.1182/blood.V83.12.3787.3787 Demirer, 1996, Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma, Bone Marrow Transplant, 17, 937 Peled, 1999, Dependence of human stem cell engraftment and repopulation of NOD-SCID mice on CXCR4, Science, 283, 845, 10.1126/science.283.5403.845 Broxmeyer, 2005, Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist, J Exp Med, 20, 1307, 10.1084/jem.20041385 Liles, 2003, Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist, Blood, 102, 2728, 10.1182/blood-2003-02-0663 Hubel, 2004, Leukocytosis and mobilization of CD34+ hematopoietic progenitor cells by AMD3100, a CXCR4 antagonist, Supportive Cancer Therapy, 1, 165, 10.3816/SCT.2004.n.008 Devine, 2004, Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma, J Clin Oncol, 22, 1095, 10.1200/JCO.2004.07.131 Flomenberg, 2005, The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone, Blood, 106, 1867, 10.1182/blood-2005-02-0468 Stiff, 2000, A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma, Bone Marrow Transplant, 26, 471, 10.1038/sj.bmt.1702531 Micallef, 2000, Factors which predict unsuccessful mobilization of perioharl blood progeniro cells following G-CSF alone in patients with non-Hodgkin's lymphoma, Hematol J, 1, 367, 10.1038/sj.thj.6200061 Surge, 2000, Characterization and outcome of hard to mobilize lymophoa patients undergoing autologiys stem cell transplantation, Leuk Lymphoma, 39, 509, 10.3109/10428190009113381 Perea, 2001, Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma, Ann Hematol, 80, 592, 10.1007/s002770100351 Gordan, 2003, Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoa patients undergoing autologous stem cell transplantation, Leuk Lymphoma, 44, 815, 10.1080/1042819031000067585 Kuittinen, 2004, Prediction of mobilization failure in patients with non-Hodgkin's lymphoma, Bone Marrow Transplant, 33, 907, 10.1038/sj.bmt.1704466 Pèrez-Simón, 1998, Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment of autologous peripheral blood progenitor cell transplantation, Transfusion, 38, 385, 10.1046/j.1537-2995.1998.38498257378.x Jagannath, 1986, High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease, Ann Intern Med, 104, 163, 10.7326/0003-4819-104-2-163 Stiff, 1998, Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens—a Southwest Oncology Group trial, J Clin Oncol, 16, 48, 10.1200/JCO.1998.16.1.48 Cortelazzo, 1997, BEAM chemotherapy and autologous hematopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma, Br J Haematol, 99, 379, 10.1046/j.1365-2141.1997.3833197.x Avalos, 1993, Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY, Bone Marrow Transplant, 12, 133 Attal, 2003, Single versus double autologous stem-cell transplantation for multiple myeloma, N Engl J Med, 349, 2495, 10.1056/NEJMoa032290 Hatse, 2002, Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4, FEBS Lett, 527, 255, 10.1016/S0014-5793(02)03143-5 Liles, 2005, Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist, Transfusion, 45, 295, 10.1111/j.1537-2995.2005.04222.x Desikan, 1998, Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma, J Clin Oncol, 16, 1547, 10.1200/JCO.1998.16.4.1547 Kroger, 1998, Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients, Br J Haematol, 102, 1101, 10.1046/j.1365-2141.1998.00865.x Meldgaard Knudsen, 2000, A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF, Bone Marrow Transplant, 26, 717, 10.1038/sj.bmt.1702609 Narayanasami, 2001, Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation, Blood, 98, 2059, 10.1182/blood.V98.7.2059 Milone, 2003, G-CSF Alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatment, Bone Marrow Transplant, 31, 747, 10.1038/sj.bmt.1703912 Meehan, 2000, Mobilization, collection, and processing of autologous peripheral blood stem cells: development of a clinical process with associated costs, J Hematother Stem Cell Res, 9, 767, 10.1089/15258160050196812 Hicks, 2007, Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells, Transfusion, 47, 629, 10.1111/j.1537-2995.2007.01164.x Weaver, 1995, An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy, Blood, 86, 3961, 10.1182/blood.V86.10.3961.bloodjournal86103961